The invention provides improved agents and methods for treatment of diseases
associated with amyloid deposits of A in the brain of a patient. Such methods
entail administering agents that induce a beneficial immunogenic response against
the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment
of Alzheimer's disease. Preferred agents including N-terminal fragments of A
and antibodies binding to the same.
